Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 COVID-19 1

Interventions

COVID-19 Vaccines 4 Blood Specimen Collection 4 Surveys and Questionnaires 3 Standard of Care 3 2019-nCoV Vaccine mRNA-1273 3 Pandemic Preparedness 2 sotrovimab 1 sinovac COVID-19 vaccine 1 selinexor 1 regorafenib 1 proxalutamide 1 monalizumab 1 lenzilumab 1 ciclesonide 1 bemcentinib 1 avdoralimab 1 acalabrutinib 1 XAV-19 1 Surgical Procedures, Operative 1 Sperm Count 1 Specimen Handling 1 Sorafenib 1 Sodium Chloride 1 Rabeprazole 1 Patient Reported Outcome Measures 1 Observation 1 Nutritional Status 1 Niclosamide 1 Meopa 1 Mastectomy, Segmental 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × COVID-19 × lenzilumab × Clear all

NCT04534725 2023-08-24

C-SMART

Peter MacCallum Cancer Centre, Australia

Phase 3 Completed

COVID-19, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡